Machine learning (ML) solutions are prevalent. However, many challenges exist in making these solutions businessgrade. One major challenge is to ensure that the ML solution provides its expected business value. In order to do that, one has to bridge the gap between the way ML model performance is measured and the solution requirements. In previous work (Barash et al. 2019) we demonstrated the effectiveness of utilizing feature models in bridging this gap. Whereas ML performance metrics, such as the accuracy or F1-score of a classifier, typically measure the average ML performance, feature models shed light on explainable data slices that are too far from that average, and therefore might indicate unsatisfied requirements. For example, the overall accuracy of a bank text terms classifier may be very high, say 98% ± 2%, yet it might perform poorly for terms that include short descriptions and originate from commercial accounts. A business requirement, which may be implicit in the training data, may be to perform well regardless of the type of account and length of the description. Therefore, the under-performing data slice that includes short descriptions and commercial accounts suggests poorly-met requirements. In this paper we show the feasibility of automatically extracting feature models that result in explainable data slices over which the ML solution under-performs. Our novel technique, IBM FreaAI aka FreaAI, extracts such slices from structured ML test data or any other labeled data. We demonstrate that FreaAI can automatically produce explainable and statistically-significant data slices over seven open datasets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.